Circadian rhythm full topic mbbs
circadian rhythm physiology MBBS complete notes sleep wake cycle suprachiasmatic nucleus
circadian rhythm suprachiasmatic nucleus diagram sleep wake cycle

An anatomical diagram of a sagittal section of the human brain illustrating the neurobiological pathways of circadian rhythm regulation. The illustration identifies the Suprachiasmatic Nucleus (SCN) as the master clock, receiving external zeitgebers such as light and food via the retino-hypothalamic pathway. Associated hypothalamic and brainstem structures labeled include the Ventrolateral Preoptic Nucleus (VLPO), Lateral Hypothalamus (LH), and Locus Coeruleus (LC). The diagram highlights the functional relationship between the SCN and the Pineal Gland (PG). It shows that melatonin secretion from the PG is modulated by circadian signaling. Furthermore, the graphic depicts a clinical intervention or physiological state where dopamine (DT) blocks melatonin secretion, which is relevant in the context of circadian rhythm sleep-wake disorders (CRSWDs) and Parkinson's disease. The color-coded cortical regions and deep brain nuclei emphasize the integrated nature of sleep-wake cycles and hormonal output.

Two sagittal brain schematics illustrating the neuroanatomical pathways of sleep-wake regulation. The left diagram shows the circadian rhythm control system, centered on the suprachiasmatic nucleus (SCN). It depicts neural signaling from the SCN to the paraventricular nucleus (PVN) and preganglionic sympathetic neurons (PSN) in the spinal cord, which subsequently stimulate the pineal gland (PG) for melatonin production. The right diagram illustrates the 'flip-flop switch' of the ascending arousal system. It highlights the inhibitory relationship between the sleep-promoting ventrolateral preoptic nucleus (VLPO), utilizing GABA and galanin, and monoaminergic/cholinergic arousal centers. Labeled nuclei include the tuberomammillary nucleus (TMN, histamine), raphe nuclei (RN, serotonin), locus coeruleus (LC, noradrenaline), perifornical area (PeF, orexin), ventral periaqueductal gray (vPAG, dopamine), and the pedunculopontine and laterodorsal tegmental nuclei (PPT/LDT, acetylcholine). The diagram demonstrates the mutual inhibition between the VLPO and the arousal system that dictates transitions between sleep and wakefulness.

A pathophysiology diagram illustrating the mechanisms of circadian rhythm entrainment by light and physical exercise. The central feature is a human brain model highlighting the Suprachiasmatic Nucleus (SCN) as the 'Central Clock' and secondary 'Oscillators.' These central structures regulate physiological sine-wave rhythms, including the sleep-wake cycle, melatonin secretion, and body temperature. The diagram shows external zeitgebers, specifically light perception/entrainment and physical exercise (represented by a cyclist), providing input to the SCN and peripheral clocks. The 'Peripheral Clocks' are depicted through anatomical illustrations of the heart, lungs, liver, kidneys, and skeletal muscle, each containing a clock face symbol. Bidirectional arrows indicate complex feedback loops between central brain regions, systemic rhythms, and peripheral organ systems, demonstrating how exercise and light synchronize multi-organ biological clocks. This visual is designed for medical education regarding chronobiology and the physiological impact of lifestyle interventions on human homeostasis.

A pathophysiology diagram illustrating the mechanisms of sleep dysfunction following Traumatic Brain Injury (TBI). The central element is a sagittal anatomical diagram of the human brain, highlighting 'Susceptible Sleep, Wake, and Circadian Circuits.' Key neuroanatomical structures indicated include the Suprachiasmatic Nucleus (SCN) for circadian rhythm, the Tuberomammillary Nucleus (TMN) for the histaminergic pathway, Orexin neurons in the posterior hypothalamus, and the Locus Coeruleus (LC) for the noradrenergic pathway. Blue and purple axonal projections are shown extending from these nuclei toward the cortex and brainstem. The diagram categorizes TBI into two phases: 1) Primary Injury, characterized by mechanical 'Sheer Force' and 'Stretching' at the skull base and basal forebrain, and 2) Secondary Injury, involving biochemical cascades such as Oxidative Stress (reactive oxygen species), Neuroinflammation, Excitotoxicity/Apoptosis, and chronic Neurodegeneration. This visual serves as an educational model for how traumatic mechanical disruption and subsequent cellular injury impair the regulatory networks of the sleep-wake cycle.
| Term | Meaning |
|---|---|
| Zeitgeber | "Time-giver" - external cue that synchronizes the clock (e.g., light, meals, exercise) |
| Entrainment | Daily resetting of the internal clock to external cues |
| Free-running rhythm | Rhythm that runs without external cues (~24.1 h in humans) |
| Phase advance | Clock shifts earlier than normal |
| Phase delay | Clock shifts later than normal |
| Chronotype | Individual preference for morning ("lark") vs. evening ("owl") activity |

CLOCK + BMAL1 (dimerize)
↓ [Transcriptional activators - daytime]
Transcription of Per (PER1, PER2, PER3) and Cry (CRY1, CRY2) genes
↓
PER and CRY proteins accumulate → form PER-CRY dimers
↓ [Enter nucleus - circadian night]
Inhibit CLOCK-BMAL1 complex → suppress their own transcription
↓
PER-CRY proteins slowly degraded (by casein kinase 1ε/δ-mediated phosphorylation → ubiquitination)
↓
CLOCK-BMAL1 disinhibited → next cycle begins (~24 h)
| Hormone | Circadian Pattern |
|---|---|
| Cortisol (ACTH) | Peak in early morning (4-10 AM); 75% of daily production |
| Melatonin | Peak at ~2 AM, suppressed in daytime |
| Growth hormone | Peak in first hour of NREM sleep |
| TSH | Nocturnal peak |
| Testosterone | Morning peak |
| Body temperature | Lowest at ~4 AM, peaks late afternoon |

| Time of light exposure | Effect on clock |
|---|---|
| Daytime | No effect |
| Just after dark | Phase delay (clock shifts later) |
| Just before dawn | Phase advance (clock shifts earlier) |
| Mutation | Phenotype |
|---|---|
| PER2 (phosphorylation site) | Familial advanced sleep phase |
| Casein kinase 1-delta | Familial advanced sleep phase |
| Knockout of PER or CRY | Arrhythmia (no circadian rhythm) |
| Drug | Mechanism | Indication |
|---|---|---|
| Melatonin | MT1/MT2 agonist | Jet lag, insomnia, circadian disorders |
| Ramelteon | MT1/MT2 agonist (selective) | Insomnia, sleep onset |
| Tasimelteon | MT1/MT2 agonist | Non-24-hour sleep-wake disorder |
| Agomelatine | MT1/MT2 agonist + 5-HT2C antagonist | Depression with circadian dysregulation |